Its spending deals could add up to roughly $1 trillion. How much revenue can that computing power support?
3 minute read
Rockstar’s long-awaited game earned a near-perfect score ahead of its U.S. launch, adding to the case for Take-Two shares.
This year, Barron’s has published a series of articles linking the birth and growth of America with the rise of financial markets. Today, why insiders at the hottest companies still hold most of the voting power.
Tactile Systems Technology is improving profitability, expanding margins, and growing market share.
Long Read
Recurring services revenue and a pending $4.2 billion Equiniti deal are helping Bullish weather sluggish digital-asset volumes.
2 minute read
Upbeat holiday commentary and a solid third quarter give shares of the T.J. Maxx parent a much-needed boost.
4 minute read
November 16, 2026
Nvidia’s stock hasn’t worked for a while now, and that was with Jensen Huang as CEO. His surprise resignation is a chance for investors to reassess.
Long Read
The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.
3 minute read
Blackstone Life Sciences agrees to pay $1.5 billion in development costs for Pfizer’s berobenatide through 2028 in exchange for milestone-based payments.
2 minute read
Optimists cite robust earnings growth; the pessimists see a bubble in danger of bursting. Plus, pro forecasts for rates, international markets, the midterm, and more.
Long Read
In our latest Big Money poll, professional investors are more upbeat than six months ago and see plenty of opportunities for stocks. Where they’re putting money to work.
Long Read
Carriers’ shares got a boost on Monday, as the worst of the weekend’s travel chaos looks to be over.
1 minute read
Buying out Double Eagle’s 40% stake lets Diamondback capture more revenue from wells it was already planning to drill.
3 minute read
The addition of Lodestar Private Asset Management brings a roster of wealthy clients including many Silicon Valley owners and executives.
2 minute read
The latest addition to Concurrent’s platform continues a year of rapid growth with assets under management now topping $30 billion.
2 minute read
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| Akanda Corp. (AKAN) | 87.80% | $3.85 |
| ClearOne Inc. (CLRO) | 60.81% | $7.59 |
| SkyAI Inc. (SKYA) | 58.93% | $3.45 |
| Cue Biopharma Inc. (CUE) | 49.82% | $4.24 |
| Netcapital Inc. (NCPL) | 32.49% | $3.14 |